The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Tenofovir-based preexposure prophylaxis for HIV infection among African women.
Open accessAbstract
BACKGROUND: Reproductive-age women need effective interventions to prevent the acquisition of human immunodeficiency virus type 1 (HIV-1) infection. METHODS: We conducted a randomized, placebo-controlled trial to assess daily treatment with oral tenofovir disoproxil fumarate (TDF), oral tenofovir-emtricitabine (TDF-FTC), or 1% tenofovir (TFV) vaginal gel as preexposure prophylaxis against HIV-1 infection in women in South Africa, Uganda, and Zimbabwe. HIV-1 testing was performed monthly, and plasma TFV levels were assessed quarterly. RESULTS: Of 12,320 women who were screened, 5029 were enrolled in the study. The rate of retention in the study was 91% during 5509 person-years of follow-up. A total of 312 HIV-1 infections occurred; the incidence of HIV-1 infection was 5.7 per 100 person-years. In the modified intention-to-treat analysis, the effectiveness was -49.0% with TDF (hazard ratio for infection, 1.49; 95% confidence interval [CI], 0.97 to 2.29), -4.4% with TDF-FTC (hazard ratio, 1.04; 95% CI, 0.73 to 1.49), and 14.5% with TFV gel (hazard ratio, 0.85; 95% CI, 0.61 to 1.21). In a random sample, TFV was detected in 30%, 29%, and 25% of available plasma samples from participants randomly assigned to receive TDF, TDF-FTC, and TFV gel, respectively. Independent predictors of TFV detection included being married, being older than 25 years of age, and being multiparous. Detection of TFV in plasma was negatively associated with characteristics predictive of HIV-1 acquisition. Elevations of serum creatinine levels were seen more frequently among participants randomly assigned to receive oral TDF-FTC than among those assigned to receive oral placebo (1.3% vs. 0.2%, P=0.004). We observed no significant differences in the frequencies of other adverse events. CONCLUSIONS: None of the drug regimens we evaluated reduced the rates of HIV-1 acquisition in an intention-to-treat analysis. Adherence to study drugs was low. (Funded by the National Institutes of Health; VOICE ClinicalTrials.gov number, NCT00705679.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Adherence can be low (48), and prevention of HIV infection, especially among women, has not been demonstrated (47,49).”
From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1011205 · Cited by 5,096
Self-citationAntiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., Katabira, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108524 · Cited by 3,256
Abdool Karim, Q., Abdool Karim, S. S., Frohlich, J. A., Grobler, A. C., Baxter, C., Mansoor, L. E., Kharsany, A. B. M., Sibeko, S., Mlisana, K. P., Omar, Z., et al. (2010) · Science · doi:10.1126/science.1193748 · Cited by 2,435
Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.
Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., Henderson, F. L., Pathak, S. R., Soud, F. A., Chillag, K. L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110711 · Cited by 1,996
Preexposure Prophylaxis for HIV Infection among African Women
Damme, L. V., Corneli, A. L., Ahmed, K., Agot, K. E., Lombaard, J. J., Kapiga, S., Malahleha, M., Owino, F., Manongi, R. N., Onyango, J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202614 · Cited by 1,633
Choopanya, K., Martin, M., Suntharasamai, P., Sangkum, U., Mock, P. A., Leethochawalit, M., Chiamwongpaet, S., Kitisin, P., Natrujirote, P., Kittimunkong, S., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61127-7 · Cited by 1,463
A Case-Cohort Design for Epidemiologic Cohort Studies and Disease Prevention Trials
Prentice, R. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.1 · Cited by 1,444
Tanser, F. C., Bärnighausen, T., Grapsa, E., Zaidi, J., & Newell, M. (2013) · Science · doi:10.1126/science.1228160 · Cited by 797
Web Resources for HIV Type 1 Genotypic-Resistance Test Interpretation
Liu, T. F., & Shafer, R. W. (2006) · Clinical Infectious Diseases · doi:10.1086/503914 · Cited by 661
Complex Surveys: A Guide to Analysis Using R
Lumley, T. (2010) · doi:10.1002/9780470580066 · Cited by 647
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 999
Hartmann, M., Lanham, M., Palanee‐Phillips, T., Mathebula, F., Tolley, E. E., Peacock, D., Pascoe, L. A., Zissette, S., Roberts, S. T., Wagner, L. D., et al. (2019) · AIDS Education and Prevention · doi:10.1521/aeap.2019.31.5.433 · Cited by 27
van Vliet, M. M., Hendrickson, C. J., Nichols, B. E., Boucher, C. A., Peters, R. P. H., & van de Vijver, D. A. M. C. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25427 · Cited by 27
HIV Antiretroviral Treatment and Pre-exposure Prophylaxis in Transgender Individuals
Poteat, T., & Radix, A. E. (2020) · Drugs · doi:10.1007/s40265-020-01313-z · Cited by 27
Wechsberg, W. M., Browne, F. A., Ndirangu, J., Bonner, C. P., Minnis, A. M., Nyblade, L. C., Speizer, I. S., Howard, B. N., MYERS, B. J., & Ahmed, K. (2020) · BMC Public Health · doi:10.1186/s12889-020-09458-y · Cited by 26
Chen, W., Ding, Y., Chen, J., Zhao, P., Wang, Z., Meng, X., Jia, T., Zheng, H., Yang, B., Luo, Z., et al. (2021) · BioMed Research International · doi:10.1155/2021/6682932 · Cited by 27
Blumenthal, J. S., Jain, S., He, F., Amico, K. R., Kofron, R., Ellorin, E. E., Stockman, J. K., Psaros, C., Ntim, G. M., Chow, K., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab328 · Cited by 27
Moss, J. A., Butkyavichene, I., Churchman, S. A., Gunawardana, M., Fanter, R. K., Miller, C. S., Yang, F., Easley, J. T., Marzinke, M. A., Hendrix, C. W., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00391-16 · Cited by 27
Gaist, P., & Stirratt, M. J. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001399 · Cited by 28
Contextual drivers of HIV risk among young African women
Mojola, S. A., & Wamoyi, J. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25302 · Cited by 24
Makarova, N., Henning, T., Taylor, A., Dinh, C. T., Lipscomb, J. T., Aubert, R. D., Hanson, D. L., Phillips, C., Papp, J. R., Mitchell, J. M., et al. (2017) · AIDS · doi:10.1097/qad.0000000000001389 · Cited by 26
Mugwanya, K. K., Baeten, J. M., Wyatt, C. M., Mugo, N., Celum, C., Ronald, A., Kiarie, J., Katabira, E. T., Heffron, R. A., & for the Partners PrEP Study and Partners Demonstration Project Teams (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001575 · Cited by 26
Utilizing emergency departments for pre‐exposure prophylaxis (PrEP)
Shull, J. A., Attys, J. M., Amutah‐Onukagha, N., & Hill, M. J. (2020) · Journal of the American College of Emergency Physicians Open · doi:10.1002/emp2.12295 · Cited by 26
A Review of Recent HIV Prevention Interventions and Future Considerations for Nursing Science
Threats, M., Brawner, B. M., Montgomery, T. M., Abrams, J. A., Jemmott, L. S., Crouch, P.-C., Freeborn, K., Kamitani, E., & Enah, C. C. (2021) · Journal of the Association of Nurses in AIDS Care · doi:10.1097/jnc.0000000000000246 · Cited by 26
Doblecki‐Lewis, S., Cohen, S. E., & Liu, A. (2015) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-015-0046-4 · Cited by 26
Murnane, P. M., Brown, E. R., Donnell, D. J., Coley, R. Y., Mugo, N., Mujugira, A., Celum, C., & Baeten, J. M. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwv202 · Cited by 26
Tyo, K. M., Vuong, H. R., Malik, D. A., Sims, L. B., Alatassi, H., Duan, J., Watson, W. H., & Steinbach-Rankins, J. M. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.08.061 · Cited by 27
Secrecy, empowerment and protection: positioning PrEP in KwaZulu-Natal, South Africa
Govender, E., Mansoor, L. E., MacQueen, K., & Karim, Q. A. (2017) · Culture Health & Sexuality · doi:10.1080/13691058.2017.1309682 · Cited by 26
HIV prevention trial design in an era of effective pre-exposure prophylaxis
Cutrell, A. G., Donnell, D. J., Dunn, D. T., Glidden, D. V., Grobler, A. C., Hanscom, B. S., Stancil, B. S., Meyer, R. D., Wang, R., & Cuffe, R. L. (2017) · HIV Clinical Trials · doi:10.1080/15284336.2017.1379676 · Cited by 26
Significant publications on infectious diseases pharmacotherapy in 2015
Babic, J. T., Sofjan, A. K., Babin, M., Echevarria, K. L., Ikwuagwu, J. O., Lam, W.-Y. M., Aitken, S. L., & Perez, K. K. (2017) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp160090 · Cited by 26
Ham, A. S., Nugent, S. T., Peters, J. J., Katz, D. F., Shelter, C. M., Dezzutti, C. S., Boczar, A. D., Buckheit, K. W., & Buckheit, R. W. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.06.010 · Cited by 26
Long-Acting HIV Treatment and Prevention: Closer to the Threshold
Barnhart, M. (2017) · Global Health Science and Practice · doi:10.9745/ghsp-d-17-00206 · Cited by 26
Current views on the potential for development of a HIV vaccine
Cohen, K. W., & Frahm, N. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1282457 · Cited by 25
for the Partners Demonstration Project Team, Pyra, M. N., Brown, E. R., Haberer, J. E., Heffron, R. A., Celum, C., Bukusi, E. A., Asiimwe, S. B., Katabira, E. T., Mugo, N., et al. (2018) · AIDS and Behavior · doi:10.1007/s10461-018-2221-3 · Cited by 25
Marrazzo, J. M., Rabe, L. K., Kelly, C., Richardson, B. A., Deal, C. D., Schwartz, J. L., Chirenje, Z. M., Piper, J. M., Morrow, R. A., Hendrix, C. W., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz045 · Cited by 26
Hart, T. A., Noor, S. W. B., Skakoon‐Sparling, S., Lazkani, S. N., Gardner, S. L., Leahy, B., Maxwell, J., Julien, R. E., Simpson, S. H., Steinberg, M., et al. (2020) · Behavior Therapy · doi:10.1016/j.beth.2020.04.005 · Cited by 25
Wand, H. C., Reddy, T., Dassaye, R., Moodley, J., Naidoo, S., & Gita Ramjee, H. (2020) · International Journal of STD & AIDS · doi:10.1177/0956462420915388 · Cited by 24
Kavanagh, M. M., Graeden, E., Pillinger, M., Singh, R., Eaneff, S., Bendaud, V., Gustav, R., & Erkkola, T. (2020) · BMJ Global Health · doi:10.1136/bmjgh-2020-003695 · Cited by 25
Understanding early uptake of PrEP by female sex workers in Zimbabwe
Busza, J. R., Phillips, A. N., Mushati, P., Chiyaka, T., Magutshwa, S., Musemburi, S., & Cowan, F. M. (2020) · AIDS Care · doi:10.1080/09540121.2020.1832192 · Cited by 25
Chai, P. R., Goodman, G. R., Bustamante, M. J., Mendez, L., Mohamed, Y., Mayer, K. H., Boyer, E. W., Rosen, R. K., & O’Cleirigh, C. M. (2020) · AIDS and Behavior · doi:10.1007/s10461-020-03082-y · Cited by 26
Romano, J., Baum, M. M., Demkovich, Z. R., Diana, F., Dobard, C., Feldman, P. L., Garcia-Lerma, J. G., Grattoni, A., Gunawardana, M., Ho, D., et al. (2021) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2021.0028 · Cited by 25
Cooper, R. L., Juárez, P. D., Morris, M. C., Ramesh, A., Edgerton, R. D., Brown, L. L., Mena, L. A., MacMaster, S. A., Collins, S. M., Juarez, P. M., et al. (2021) · INQUIRY The Journal of Health Care Organization Provision and Financing · doi:10.1177/00469580211017666 · Cited by 25
Understanding PrEP decision making among pregnant women in Lilongwe, Malawi: A mixed‐methods study
Hill, L. M., Golin, C. E., Saidi, F., Phanga, T., Tseka, J., Young, A. M., Pearce, L. D., Maman, S., Chi, B. H., & Mutale, W. (2022) · Journal of the International AIDS Society · doi:10.1002/jia2.26007 · Cited by 24
Shuper, P. A., Varatharajan, T., Kinitz, D. J., Gesink, D., Joharchi, N., Bogoch, I. I., Loutfy, M. R., & Rehm, J. T. (2022) · BMC Public Health · doi:10.1186/s12889-022-14279-2 · Cited by 25
Gandhi, M., Glidden, D. V., Chakravarty, D., Wang, G., Biwott, C., Mogere, P., Maina, G., Njeru, I., Kiptinness, C., Okello, P., et al. (2024) · The Lancet HIV · doi:10.1016/s2352-3018(24)00125-5 · Cited by 25
Ramanathan, R., Jiang, Y., Read, B. J., Golan‐Paz, S., & Woodrow, K. A. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.02.034 · Cited by 25
Primary Care for Men Who Have Sex with Men
Wilkin, T. J. (2015) · New England Journal of Medicine · doi:10.1056/nejmcp1401303 · Cited by 26
Rodríguez‐García, M., Patel, M. V., Shen, Z., Bodwell, J. E., Rossoll, R. M., & Wira, C. R. (2017) · Scientific Reports · doi:10.1038/srep45725 · Cited by 25
Chan, P. A., Goedel, W. C., Nunn, A. S., Sowemimo-Coker, G., Galárraga, O., Prosperi, M., Patel, R. R., Mena, L. A., Montgomery, M. C., & Marshall, B. D. L. (2019) · AIDS Patient Care and STDs · doi:10.1089/apc.2019.0064 · Cited by 25
Liu, A., Islas, C. P. D., Gundacker, H. M., Neradilek, B., Hoesley, C. J., van der Straten, A., Hendrix, C. W., Beamer, M. A., Jacobson, C. E., McClure, T., et al. (2021) · Journal of the International AIDS Society · doi:10.1002/jia2.25747 · Cited by 25
Fan, M. D., Kramzer, L. F., Hillier, S. L., Chang, J. C., Meyn, L. A., & Rohan, L. C. (2016) · Archives of Sexual Behavior · doi:10.1007/s10508-016-0816-1 · Cited by 25
Peng, Q., Liu, X., Tang, X., Zhang, Q., Zhao, J., Zheng, C., Zhao, F., Zhou, Y., Zhang, L., Sun, L., et al. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002510 · Cited by 24
Pre-exposure prophylaxis for South African adolescents: What evidence?
Bekker, L., Gill, K., & Wallace, M. (2015) · South African Medical Journal · doi:10.7196/samj.2015.v105i11.10222 · Cited by 24
das Neves, J., Martins, J. P., & Sarmento, B. F. C. C. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.015 · Cited by 24
Integrating oral PrEP delivery among African women in a large HIV endpoint‐driven clinical trial
Beesham, I., Welch, J. D., Heffron, R. A., Pleaner, M., Kidoguchi, L., Palanee‐Phillips, T., Ahmed, K., Baron, D., Bukusi, E. A., Louw, C. E., et al. (2020) · Journal of the International AIDS Society · doi:10.1002/jia2.25491 · Cited by 24
Rosenberg, N. E., Kudowa, E., Price, J. T., Pettifor, A. E., Bekker, L., Hosseinipour, M. C., & Chagomerana, M. (2020) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001242 · Cited by 26
Medina‐Marino, A., Bezuidenhout, D., Hosek, S., Barnabas, R. V., Atujuna, M., Bezuidenhout, C., Ngwepe, P., Peters, R. P. H., Little, F., Celum, C., et al. (2021) · Trials · doi:10.1186/s13063-021-05402-6 · Cited by 25
Celum, C., Seidman, D. L., Travill, D., Dehlendorf, C. E., Gumede, S., Zewdie, K., Wilson, W., Morton, J. F., Baeten, J. M., Donnell, D. J., et al. (2023) · Journal of the International AIDS Society · doi:10.1002/jia2.26154 · Cited by 24
Protein/peptide‐based entry/fusion inhibitors as anti‐HIV therapies: challenges and future direction
Fumakia, M., Yang, S., Gu, J., & Ho, E. A. (2015) · Reviews in Medical Virology · doi:10.1002/rmv.1853 · Cited by 24
Hummert, P., Parsons, T. L., Ensign, L. M., Hoang, T., & Marzinke, M. A. (2018) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2018.02.011 · Cited by 24
John, S. A., Rendina, H. J., Starks, T. J., Grov, C., & Parsons, J. T. (2019) · AIDS Patient Care and STDs · doi:10.1089/apc.2018.0136 · Cited by 24
Goodman‐Meza, D., Beymer, M. R., Kofron, R., Amico, K. R., Psaros, C., Bushman, L. R., Anderson, P. L., Bolan, R., Jordan, W. C., Rooney, J. F., et al. (2019) · AIDS Care · doi:10.1080/09540121.2019.1595523 · Cited by 23
A decade of sustained geographic spread of HIV infections among women in Durban, South Africa
Gita Ramjee, H., Sartorius, B. K. D., Morris, N., Wand, H. C., Reddy, T., Yssel, J. D., & Tanser, F. C. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4080-6 · Cited by 23
Larsen, A., Kinuthia, J., Lagat, H., Sila, J., Abuna, F., Kohler, P. K., John-Stewart, G. C., & Pintye, J. C. (2020) · International Journal of STD & AIDS · doi:10.1177/0956462420920423 · Cited by 23
Ngure, K., Mugo, N. R., Bukusi, E. A., Kiptinness, C., Oware, K., Gakuo, S., Musinguzi, N., Pyra, M. N., Garrison, L., Baeten, J. M., et al. (2021) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002793 · Cited by 23
Garcia‐Cremades, M., Vučićević, K. M., Hendrix, C. W., Jayachandran, P., Jarlsberg, L. G., Grant, R. M., Celum, C., Martin, M., Baeten, J. M., Marrazzo, J. M., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac313 · Cited by 23
Moore, M., Stansfield, S. E., Donnell, D. J., Boily, M., Mitchell, K. M., Anderson, P. L., Delany‐Moretlwe, S., Bekker, L., Mgodi, N. M., Celum, C., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02564-5 · Cited by 23
Dynamic choice HIV prevention intervention at outpatient departments in rural Kenya and Uganda
Koss, C. A., Ayieko, J., Kabami, J., Balzer, L. B., Kakande, E. R., Sunday, H., Nyabuti, M., Wafula, E. M., Shade, S. B., Biira, E., et al. (2023) · AIDS · doi:10.1097/qad.0000000000003763 · Cited by 23
Duby, Z., Hartmann, M., Montgomery, E., Colvin, C. J., Mensch, B., & van der Straten, A. (2015) · Culture Health & Sexuality · doi:10.1080/13691058.2015.1064165 · Cited by 23
Guthrie, K. M., DUNSIGER, S. I., Vargas, S. E., Fava, J. L., Shaw, J. G., Rosen, R. K., Kiser, P. F., Kojic, E. M., Friend, D. R., & Katz, D. F. (2016) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2015.0275 · Cited by 24
Derby, N. R., Aravantinou, M., Kenney, J., Ugaonkar, S. R., Wesenberg, A., Jolanta, W., Kizima, L., Rodríguez, A., Zhang, S., Mizenina, O. A., et al. (2017) · Drug Delivery and Translational Research · doi:10.1007/s13346-017-0389-0 · Cited by 23
Chuchuen, O., Maher, J. R., Henderson, M. H., DeSoto, M. G., Rohan, L. C., Wax, A. P., & Katz, D. F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185633 · Cited by 25
HIV Antiretroviral Pre‐Exposure Prophylaxis: Development Challenges and Pipeline Promise
Hendrix, C. W. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1227 · Cited by 23
Hu, Y. Y., Zhong, X., Peng, B., Zhang, Y., Liang, H., Dai, J., Zhang, J., & Huang, A. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3497-7 · Cited by 24
Mechanistic framework predicts drug-class specific utility of antiretrovirals for HIV prophylaxis
Duwal, S., Dickinson, L., Khoo, S., & von Kleist, M. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006740 · Cited by 23
Elmes, J., Silhol, R., Hess, K. L., Gedge, L. M., Nordsletten, A. E., Staunton, R., Anton, P. A., Shacklett, B. L., McGowan, I., Dang, Q., et al. (2020) · American Journal of Reproductive Immunology · doi:10.1111/aji.13263 · Cited by 21
Loevinsohn, G. S., Kigozi, G., Kagaayi, J., Wawer, M. J., Nalugoda, F. K., Chang, L. W., Quinn, T. C., Serwadda, D. M., Reynolds, S. J., Nelson, L. J., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1533 · Cited by 23
on behalf of the Partners Demonstration Project Team, Musinguzi, N., Kidoguchi, L., Mugo, N., Ngure, K., Katabira, E. T., Celum, C., Baeten, J. M., Heffron, R. A., & Haberer, J. E. (2020) · BMC Public Health · doi:10.1186/s12889-020-09712-3 · Cited by 22
Dietrich, J. J., Atujuna, M., Tshabalala, G., Hornschuh, S., Mulaudzi, M., Koh, M., Ahmed, N., Muhumuza, R., Ssemata, A. S., Otwombe, K. N., et al. (2021) · BMC Health Services Research · doi:10.1186/s12913-020-05942-8 · Cited by 22
Stalter, R. M., Pintye, J. C., & Mugwanya, K. K. (2021) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2021.1931680 · Cited by 22
Long-Acting Cabotegravir for HIV/AIDS Prophylaxis
Engelman, K. D., & Engelman, A. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00157 · Cited by 22
Changing the PrEP Narrative: A Call to Action to Increase PrEP Uptake among Women
Cernasev, A., Walker, C. M., Armstrong, D. L., & Golden, J. (2021) · Women · doi:10.3390/women1020011 · Cited by 22
The European preexposure prophylaxis revolution
Cairns, G., McCormack, S., & Molina, J. (2015) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000223 · Cited by 22
Dimitrov, D., Boily, M., Hallett, T. B., Albert, J., Boucher, C. A., Mellors, J. W., Pillay, D., & van de Vijver, D. A. M. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158620 · Cited by 22
Owen, B. N., Elmes, J., Silhol, R., Dang, Q., McGowan, I., Shacklett, B. L., Swann, E. M., van der Straten, A., Baggaley, R. F., & Boily, M. (2017) · Journal of the International AIDS Society · doi:10.7448/ias.20.1.21162 · Cited by 22
Stabilization and Sustained Release of HIV Inhibitors by Encapsulation in Silk Fibroin Disks
Zhang, L., Herrera, C., Coburn, J. M., Olejniczak, N. J., Ziprin, P., Kaplan, D. L., & LiWang, P. J. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00167 · Cited by 22
Pharmacology of Antiretrovirals in the Female Genital Tract for HIV Prevention
Nicol, M. R., Corbino, J. A., & Cottrell, M. L. (2018) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1270 · Cited by 22
Measuring Adherence to Antiretroviral Therapy via Hair Concentrations in India
Gandhi, M., Devi, S., Bacchetti, P., Chandy, S., Heylen, E., Phung, N., Kuncze, K., Okochi, H., Kumar, R. A., Kurpad, A. V., et al. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001993 · Cited by 23
Holmes, L., Kaufman, M. R., Casella, A., Mudavanhu, M., Mutunga, L., Polzer, T., Bassett, J., Rie, A. V., & Schwartz, S. (2020) · Journal of the International AIDS Society · doi:10.1002/jia2.25521 · Cited by 21
Dezzutti, C. S., Yandura, S. E., Wang, L. Q., Moncla, B. J., Teeple, E. A., Devlin, B., Nuttall, J. P., Brown, E. R., & Rohan, L. C. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1738-7 · Cited by 23
Adaptive non-inferiority margins under observable non-constancy
Hanscom, B. S., Hughes, J. P., Williamson, B. D., & Donnell, D. J. (2018) · Statistical Methods in Medical Research · doi:10.1177/0962280218801134 · Cited by 22
The Utility of Efavirenz-based Prophylaxis Against HIV Infection. A Systems Pharmacological Analysis
Duwal, S., Seeler, D., Dickinson, L., Khoo, S., & von Kleist, M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00199 · Cited by 22
Impact of Sex on the Pharmacokinetics and Pharmacodynamics of 1% Tenofovir Gel
Herold, B. C., Chen, B. A., Salata, R. A., Marzinke, M. A., Kelly, C. W., Dezzutti, C. S., McGowan, I., Galaska, B., Levy, L., Piper, J. M., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ913 · Cited by 21
Peterson, K., Foláyan, M. O., Chigwedere, E., & Nthete, E. (2015) · Anthropology and Medicine · doi:10.1080/13648470.2015.1081377 · Cited by 21
John, S. A., Quinn, K. G., Pleuhs, B., Walsh, J. L., & Petroll, A. E. (2020) · AIDS and Behavior · doi:10.1007/s10461-020-02866-6 · Cited by 21
Fonner, V. A., Ntogwisangu, J., Hamidu, I., Joseph, J., Fields, J., Evans, E., Kilewo, J., Bailey, C., Goldsamt, L. A., Fisher, C. B., et al. (2021) · BMC Public Health · doi:10.1186/s12889-021-10707-x · Cited by 23
Why Do We Need New Drug Classes for HIV Treatment and Prevention?
Waheed, A., & Tachedjian, G. (2016) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616999151013124606 · Cited by 19
Prevention of vaginal and rectal HIV transmission by antiretroviral combinations in humanized mice
Gallay, P. A., Chatterji, U., Kirchhoff, A. M., Gandarilla, A., Gunawardana, M., Pyles, R. B., Marzinke, M. A., Moss, J. A., & Baum, M. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184303 · Cited by 21
Farcasanu, M., & Kwon, D. S. (2018) · Current HIV/AIDS Reports · doi:10.1007/s11904-018-0380-5 · Cited by 21
Dockendorf, M. F., Murthy, G., Bateman, K. P., Kothare, P. A., Anderson, M., Xie, I., Sachs, J. R., Burlage, R., Goldman, A., Moyer, M., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1142 · Cited by 21
In-capillary microextraction for direct mass spectrometry analysis of biological samples
Ren, Y., Zhang, W., Lin, Z., Bushman, L. R., Anderson, P. L., & Ouyang, Z. (2018) · Talanta · doi:10.1016/j.talanta.2018.07.027 · Cited by 21
Zheng, Z., Qiu, J., Gu, J., Xu, H., Cheng, W., & Hao, C. (2018) · International Journal of STD & AIDS · doi:10.1177/0956462418781142 · Cited by 21
Gbadamosi, S. O., Itanyi, I. U., Menson, W. N. A., Olawepo, J. O., Bruno, T., Ogidi, A. G., Patel, D. V., Oko, J. O., Onoka, C. A., & Ezeanolue, E. E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211022 · Cited by 21
Guillamet, L. J. V., Moll, A. P., Kacin, A. J., Ndlovu, N. E., & Shenoi, S. (2019) · AIDS Patient Care and STDs · doi:10.1089/apc.2018.0242 · Cited by 22
Giardina, F., Romero-Severson, E. O., Axelsson, M., Svedhem, V., Leitner, T., Britton, T., & Albert, J. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyz100 · Cited by 21
Shah, M. D., Gillespie, S. E., Holt, S., Morris, C. R., & Camacho-González, A. (2019) · AIDS Patient Care and STDs · doi:10.1089/apc.2019.0109 · Cited by 21
Drain, P. K., Ngure, K., Mugo, N., Spinelli, M. A., Chatterjee, P., Bacchetti, P., Glidden, D. V., Baeten, J. M., & Gandhi, M. (2019) · JMIR Research Protocols · doi:10.2196/15029 · Cited by 21
Factors associated with bone mineral density in healthy African women
for the MTN-003B Protocol Team, Mgodi, N. M., Kelly, C., Gati, B. M., Greenspan, S. L., Dai, J. Y., Bragg, V., Livant, E., Piper, J. M., Nakabiito, C., et al. (2015) · Archives of Osteoporosis · doi:10.1007/s11657-015-0206-7 · Cited by 21
Setting the stage for expanding HIV pre-exposure prophylaxis use in Canada
Hull, M., & Tan, D. (2017) · Canada Communicable Disease Report · doi:10.14745/ccdr.v43i12a05 · Cited by 17
Srinivasan, S., Richardson, B. A., Wallis, J. M., Fiedler, T. L., Strenk, S. M., Hoffman, N. G., Proll, S. C., Chirenje, Z. M., Livant, E., Fredricks, D. N., et al. (2024) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiae406 · Cited by 20
Sims-Haynes, A., Markham, C. M., Schick, V., Suchting, R., Parthasarathy, N., Choudhury, S., & Hill, M. J. (2024) · AIDS and Behavior · doi:10.1007/s10461-024-04491-z · Cited by 25
Metadata
- Authors
- Marrazzo, J. M., Ramjee, G., Richardson, B. A., Gomez, K., Mgodi, N., Nair, G., Palanee, T., Nakabiito, C., van der Straten, A., Noguchi, L., Hendrix, C. W., Dai, J. Y., Ganesh, S., Mkhize, B., Taljaard, M., Parikh, U. M., Piper, J., Mâsse, B., Grossman, C., Rooney, J., Schwartz, J. L., Watts, H., Marzinke, M. A., Hillier, S. L., McGowan, I. M., & Chirenje, Z. M.
- Affiliations
- University of California, San Francisco (US)
- Harborview Medical Center (US)
- Family Health International 360 (US)
- University of Zimbabwe (ZW)
- Centre for the AIDS Programme of Research in South Africa (ZA)
- University of Pittsburgh (US)
- Johns Hopkins University (US)
- South African Medical Research Council (ZA)
- National Institutes of Health (US)
- Eastern Virginia Medical School (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-02-05
- Volume
- 372
- Issue
- 6
- Pages
- 509-518
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4341965
- OpenAlex
- W2044369525
- Cited by
- 1,296
- References
- 19
- Citations by year
- 2026: 32 · 2025: 54 · 2024: 59 · 2023: 78 · 2022: 93 · 2021: 143 · 2020: 125 · 2019: 139 · 2018: 122 · 2017: 140 · 2016: 175 · 2015: 131
- FWCI
- 147.62
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- ResearchSpace (University of KwaZulu-Natal) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (U01AI068633, UM1AI068615, UM1AI069422, UM1AI106707, UM1AI069436, P30AI094189, UM1AI069530, UM1AI069463, UM1AI069469)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Keywords
- tenofovir disoproxil fumarate, tenofovir/emtricitabine, HIV pre-exposure prophylaxis, HIV-1 prevention, women, women of reproductive age, antiretroviral resistance, tenofovir resistance, drug safety, adverse events, creatinine elevation
- MeSH terms
- Emtricitabine, Tenofovir, Adenine, Administration, Intravaginal, Administration, Oral, Adolescent, Adult, Deoxycytidine, Drug Therapy, Combination, Female, HIV Seropositivity, Humans, Middle Aged, Surveys and Questionnaires, HIV-1, HIV Infections, Africa South of the Sahara, Drug Resistance, Viral, Anti-Retroviral Agents, Medication Adherence, Young Adult, Organophosphonates, Pre-Exposure Prophylaxis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
